Beijing Konruns Pharmaceutical Co.,Ltd. (SHA:603590)
China flag China · Delayed Price · Currency is CNY
42.15
-0.11 (-0.26%)
At close: Feb 13, 2026

SHA:603590 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Operating Revenue
870.34824.43917.75851.05693.03808.64
Other Revenue
0.970.972.2615.68116.76-
871.31825.4920.01866.73809.78808.64
Revenue Growth (YoY)
2.96%-10.28%6.15%7.03%0.14%-24.14%
Cost of Revenue
85.7186.26101.05126.65105.7659.25
Gross Profit
785.59739.14818.96740.07704.02749.4
Selling, General & Admin
567.88553.76583.28525.88479.34535.52
Research & Development
52.754.9494.9186.78102.2793.11
Other Operating Expenses
8.386.755.646.048.6911.82
Operating Expenses
643.9620.37689.42620.56591.51637.72
Operating Income
141.69118.77129.54119.51112.51111.67
Interest Expense
-7.18-6.16-2.78-0.86-1.41-0.42
Interest & Investment Income
25.9430.9819.3318.5224.5759.96
Currency Exchange Gain (Loss)
-1.29-1.290.50.260.31-0
Other Non Operating Income (Expenses)
-13.75-1.56-1.7-0.361.58-2.04
EBT Excluding Unusual Items
145.4140.74144.9137.06137.57169.17
Impairment of Goodwill
-97.64-97.64----
Gain (Loss) on Sale of Investments
-1.28-0.49-12.78-7.6535.641.36
Gain (Loss) on Sale of Assets
0.11-0.03-0.13-0.010-0.08
Asset Writedown
-7.77-7.77--4.06--
Other Unusual Items
4.054.05-9.2614.9815.6437.57
Pretax Income
42.8638.86122.73140.32188.86208.02
Income Tax Expense
10.5517.33-64.8416.4221.4224.67
Earnings From Continuing Operations
32.3121.53187.57123.89167.44183.35
Minority Interest in Earnings
24.8120.69-37.12-22.4-19.460
Net Income
57.1242.22150.45101.49147.99183.36
Net Income to Common
57.1242.22150.45101.49147.99183.36
Net Income Growth
-50.24%-71.94%48.24%-31.42%-19.29%-31.09%
Shares Outstanding (Basic)
157156157156157159
Shares Outstanding (Diluted)
157156157156157159
Shares Change (YoY)
0.03%-0.23%0.37%-0.82%-1.26%-0.53%
EPS (Basic)
0.360.270.960.650.941.15
EPS (Diluted)
0.360.270.960.650.941.15
EPS Growth
-50.26%-71.88%47.69%-30.85%-18.26%-30.72%
Free Cash Flow
62.2268.2298.4423.38-108.438.03
Free Cash Flow Per Share
0.400.440.630.15-0.690.05
Dividend Per Share
0.6000.6000.3000.2000.3000.350
Dividend Growth
100.00%100.00%50.00%-33.33%-14.29%-30.00%
Gross Margin
90.16%89.55%89.02%85.39%86.94%92.67%
Operating Margin
16.26%14.39%14.08%13.79%13.89%13.81%
Profit Margin
6.56%5.12%16.35%11.71%18.27%22.68%
Free Cash Flow Margin
7.14%8.27%10.70%2.70%-13.39%0.99%
EBITDA
163.77146.73165.35151.54144.29141.71
EBITDA Margin
18.80%17.78%17.97%17.48%17.82%17.52%
D&A For EBITDA
22.0827.9635.832.0331.7830.04
EBIT
141.69118.77129.54119.51112.51111.67
EBIT Margin
16.26%14.39%14.08%13.79%13.89%13.81%
Effective Tax Rate
24.62%44.60%-11.70%11.34%11.86%
Revenue as Reported
871.31825.4920.01866.73809.78808.64
Advertising Expenses
---32.55350.29448.58
Source: S&P Global Market Intelligence. Standard template. Financial Sources.